<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 04 Mar 2021 07:43:18 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>行业政策|2020年国内干细胞相关政策汇总，相关产业值得期待！</title><link>https://mp.weixin.qq.com/s/yeubq3jbJo2uu2XPZQnExA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODSLLhQhoSavCYzd1miaIDL2L6Lbd0hWBTJ2NEgs20LTR32XJG9FVeeanA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>原料药关键工艺参数的研究思路解析</title><link>https://mp.weixin.qq.com/s/Iu1WNKpjxyLW3m39CljKXg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODS0QpgCMGfgNs99aibzeO4OmqzjDRLTdHibm94Qyn4uZEFIJhDDOL7gmsQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>国外2020年61个单抗产品销售额总计已超1500亿美元</title><link>https://mp.weixin.qq.com/s/7lv92vlqtJxkRrcejlr2Kw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODSl2z8L0Bu2e0jQTvs2tH0Fx8mibzXgK31QHTXZdh77VKNwzcLQOUEbLA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>最近，随着各大公司年报的逐渐出炉，笔者汇总整理了国外61个抗体药物的2020年最新销售数据和其他年度数据。]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>​【精选】专利视角下石墨烯在生物医药领域的研究进展</title><link>https://mp.weixin.qq.com/s/09OG5888ktzynbDSF2ggaw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia89Ljnp8Q0sgjnGQTUbkODSX3IicD0Lf6iafY4j67eZL6h5mOuXbV3uZmBoTPQdbxn3mhicJib05cSYvQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:02:26 +0800</pubDate></item><item><title>强生腺病毒载体新冠疫苗FDA申报紧急上市答辩PPT</title><link>https://mp.weixin.qq.com/s/ziAhHp7r4Ts5O9a3RoRwDg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJPzeJLWkZSDheiafrF84wNAT8a6JpBRrU7oXMBMpLho5GfSicSdLKcyug/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item><item><title>NMPA综合司再次公开征求《疫苗生产流通管理规定（征求意见稿）》意见</title><link>https://mp.weixin.qq.com/s/Fl82giLVN0vPO6p-uucdZg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJ5aR99YaHqOUCQV5nCDTYJsaGagOKfcUiavxlEs5LAAGgvricB9Fic7yRA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item><item><title>某药监局发布《药品生产监督检查缺陷整改指南》！</title><link>https://mp.weixin.qq.com/s/Mv6GZ8UhBp1Pp_6RGcZEjQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJakH7kELK1T7A7gxjf9E3ohmAl7l33zZGqh8ySjE7icf2270ua62GiczQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item><item><title>李宾讲临床丨方案设计与风险规避</title><link>https://mp.weixin.qq.com/s/md2rBzwTDSMyqQ2pHWOeOg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9zNibibZSxDiamGSEDE0yzlmJ8B9uLHzNicBQaNhIgiacJAVI6oTFM7mJ5NyYwf5BBcV16JyicX167dibFQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>风险管理的理念应该贯穿方案设计的始终。]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:24:49 +0800</pubDate></item><item><title>药物杂质遗传毒性评价策略与监管研究</title><link>https://mp.weixin.qq.com/s/Hv-kqKBTNJgkjNLxkksHAw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia93xGo2bOhbyWUMpa7zOyujTicIhSFibfYE3JjoTYBaWIr3nDKhckibQsRtibicCQheYQXMSZq8htibiauAA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Mon, 01 Mar 2021 19:19:06 +0800</pubDate></item><item><title>AASLD会议共识：肝细胞癌的临床试验设计和终点</title><link>https://mp.weixin.qq.com/s/lAMykrPxa4ekekk8O4biZw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia93xGo2bOhbyWUMpa7zOyujjrzWpbhC2d93F5yk6XqKmEoZuR2rouvR0ogibPcZxdNLPYW0FfztoQQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Mon, 01 Mar 2021 19:19:06 +0800</pubDate></item><item><title>《生物制品批签发管理办法》今日实施</title><link>https://mp.weixin.qq.com/s/M0AKbgkv4Wu0Aa9SS2kPDQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia93xGo2bOhbyWUMpa7zOyuj7D6HSGP4MPzl8eLhOibFibF0ZBaBuoy9mXR6Yo1LWKdCuklUfpLgYMQQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本文对《生物制品批签发管理办法》中的重点事项和工作流程进行了梳理，便于大家理解和实际执行。]]></content:encoded><pubDate>Mon, 01 Mar 2021 19:19:06 +0800</pubDate></item><item><title>如何解读ICH指导原则中的杂质三限（报告限，鉴定限，界定限）</title><link>https://mp.weixin.qq.com/s/4OsbzIFv4c_jzOn4KH8uSQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia8fFGSaNcQfG827Q2Jglv9YMiaJu9yNwm1Wp3Ew2dEOqiajraaibIouoaSW26VOIibutTL1wh3VOjQCsg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sun, 28 Feb 2021 18:56:01 +0800</pubDate></item><item><title>提高双特异性抗体生产和质量的策略</title><link>https://mp.weixin.qq.com/s/93nhV2kDadn3i2K1TRcTGw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia8fFGSaNcQfG827Q2Jglv9YlEIYQQJD94jypj0XgxOgNRjTrd69w46zH7TS76lsSGC0uJeicUvZlWA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本文基于这两种主要的双特异性抗体类型，描述了其在设计，生产和质量方面的最新研究进展和性能提升的策略。]]></content:encoded><pubDate>Sun, 28 Feb 2021 18:56:01 +0800</pubDate></item><item><title>注射剂一致性评价的全流程药学要求</title><link>https://mp.weixin.qq.com/s/Arquc59z-ByV53EnfP3wnQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia8fFGSaNcQfG827Q2Jglv9YQ9qzFIM4H8eiaGycmQAnZiaHBe4Vo5rxrna23WbMR2ibdF8ibFVK57hnYA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sun, 28 Feb 2021 18:56:01 +0800</pubDate></item><item><title>Nat Rev| 抗体偶联药物ADC从理念到临床</title><link>https://mp.weixin.qq.com/s/uz-jsMPmYxx7OFo2ZDJKoQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia8fFGSaNcQfG827Q2Jglv9Y9QOZeuqC72lzZXRUKmc4Jvk9VLFkCqLplhklKyibibwHX7OINCAssBibQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>提出几种假设和新颖的ADC设计策略，以最大限度地发挥ADC药物的优势，为癌症患者提供的潜在好处。]]></content:encoded><pubDate>Sun, 28 Feb 2021 18:56:01 +0800</pubDate></item><item><title>《药品注册管理办法》48个热点问题答疑</title><link>https://mp.weixin.qq.com/s/y-bCRSWwQkzVABdHpKE6bA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibS9kFJDia5WicU67QyZOpgvdV43zVQWbSJDIPQz4u2jFYK99GkQQ2zDsrJ5WfiaKWJupBXy3ZQpfeEA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 27 Feb 2021 23:00:47 +0800</pubDate></item><item><title>科学家研制超级“NK细胞”，更强的活性，抵御外来细胞</title><link>https://mp.weixin.qq.com/s/RjvlnxE6tymJHGgm-1JbiQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibS9kFJDia5WicU67QyZOpgvdp4N0p10cUgdasSzNupkzkXLfxFbEIPsAhicNhpuqUgZQyUD6wQtgD0g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 27 Feb 2021 23:00:47 +0800</pubDate></item><item><title>NMPA I 批准注册117个医疗器械产品的公告（2021年1月）（2021年 第26号）</title><link>https://mp.weixin.qq.com/s/88ppsC-xukLZKzX7OagyQA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUiaibS9kFJDia5WicU67QyZOpgvdzk0Oc9JF4q3czhN5oSkSP0hFL41vtrWLaAP6Zmu1KSAom9wsH3fOcQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sat, 27 Feb 2021 23:00:47 +0800</pubDate></item><item><title>【CDE文章】多规格口服固体制剂仿制药生物豁免的药学考虑</title><link>https://mp.weixin.qq.com/s/uEqq_OfiYFjSHOpuznIZuA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9ly0eMcDBd8SbzEqlDt4GVXJnpehDK4lvdUic8zHeiclxEzfvrt1mxpmJQInUvT2AGfRTlOVKl2pAQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 26 Feb 2021 23:13:28 +0800</pubDate></item><item><title>【周立春】工艺变更申报与注册工艺核查的政策解读</title><link>https://mp.weixin.qq.com/s/qm8U8alrczQhBwC24VDYkQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/RlL1PJvyUia9ly0eMcDBd8SbzEqlDt4GV6HEHmX6dmziaAYmaF5cwXEtLjAS1sknicAGPzbhUQQdiavXBEYc40rYSg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Fri, 26 Feb 2021 23:13:28 +0800</pubDate></item></channel></rss>